Equity Research, Broker Reports, and media content on Shield Therapeutics Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Shield Therapeutics Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Shield Therapeutics Plc

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Shield Therapeutics Plc. We currently have 361 research reports from 9 professional analysts.

  • Open: 6.50p
  • Range Today: 6.40/6.59p
  • 52 Week: 5.36/36.9p
  • Daily Volume: 344.6k
  • Daily Liquidity: 0.06%
  • # Shares: 585.7m
  • Market Cap: £38.1m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
23Jan23 11:15 DGAP-News Hardman & Co Q&A on Shield Therapeutics (STX): Positioned for profitability with Viatris deal and its additional capital
13Jan23 10:30 RNS Shield Therapeutics - Holding(s) in Company
13Jan23 07:15 DGAP-News Hardman & Co Research: Shield Therapeutics (STX) - Positioned for growth and profitability
12Jan23 14:40 RNS Shield Therapeutics - Holding(s) in Company
12Jan23 14:15 RNS Shield Therapeutics - Holding(s) in Company
09Jan23 17:10 RNS Shield Therapeutics - Partial AOP Loan Conversion
09Jan23 15:56 RNS Shield Therapeutics - Holding(s) in Company
  • Frequency of research reports

     

  • Research reports on

    Shield Therapeutics Plc

  • Providers covering

    Shield Therapeutics Plc